Back to today’s briefing

Story perspectives

CAR T-Cell Therapy Hurdles: Funding and Logistics Issues

6/6/2025

31 4

Summary

Story summary

CAR T-cell therapies hold immense promise, yet a new IQVIA report reveals significant hurdles in their delivery across Australia, Canada, Europe, and the UK. Health systems grapple with logistical and financial challenges, underscoring the need for better funding, streamlined referral processes, and robust data infrastructure to ensure these groundbreaking treatments reach those in need.

1 of 1

Story summary

CAR T-cell therapies hold immense promise, yet a new IQVIA report reveals significant hurdles in their delivery across Australia, Canada, Europe, and the UK. Health systems grapple with logistical and financial challenges, underscoring the need for better funding, streamlined referral processes, and robust data infrastructure to ensure these groundbreaking treatments reach those in need.